Monopar Therapeutics Inc. (MNPR)

Every figure this model derived for MNPR, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
cash 105,370,465 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 134,763,709 AssetsCurrent 2026-06-30
current liabilities 4,016,031 LiabilitiesCurrent 2026-06-30
equity 130,854,970 StockholdersEquity 2026-06-30
ocf -12,181,947 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 0 Revenues 2026-06-30
sbc 5,324,745 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up MNPR on one particular measure came for.

RatioValue
current ratio33.56
current ratio reported33.56
dilution pct95.62
roic-68.56

What to be careful about

What this model itself distrusts about MNPR's figures. Written by the derivation as it ran, not added afterwards.